Xylem Analysts Lower Their Forecasts After Q4 Results

Benzinga

02/12

Xylem Inc (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.

The company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.

Xylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.

“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”

Xylem shares dipped 2.1% to trade at $126.24 on Wednesday.

These analysts made changes to their price targets on Xylem following earnings announcement.

Barclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.
RBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.

Considering buying XYL stock? Here’s what analysts think:

Photo via Shutterstock

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2610950767"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610950767\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610950767?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-12 02:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610950767","market":"us","top_or_hot":-1,"title":"Xylem Analysts Lower Their Forecasts After Q4 Results","media":"Benzinga","content":"<html><body><p><strong>Xylem Inc</strong> (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.</p>\n<p>The company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.</p>\n<p>Xylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.</p>\n<p>“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”</p>\n<p>Xylem shares dipped 2.1% to trade at $126.24 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Xylem following earnings announcement.</p>\n<ul>\n<li>Barclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.</li>\n<li>RBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.</li>\n</ul>\n<p><strong>Considering buying XYL stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"202\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-1024x202.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-1024x202.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-300x59.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-768x152.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229.png 1250w\" width=\"1024\"/></figure>\n<p>Photo via Shutterstock</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xylem Analysts Lower Their Forecasts After Q4 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXylem Analysts Lower Their Forecasts After Q4 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2026-02-12 02:23</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Xylem Inc</strong> (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.</p>\n<p>The company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.</p>\n<p>Xylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.</p>\n<p>“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”</p>\n<p>Xylem shares dipped 2.1% to trade at $126.24 on Wednesday.</p>\n<p>These analysts made changes to their price targets on Xylem following earnings announcement.</p>\n<ul>\n<li>Barclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.</li>\n<li>RBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.</li>\n</ul>\n<p><strong>Considering buying XYL stock? Here’s what analysts think:</strong> </p>\n<figure><img decoding=\"async\" height=\"202\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-1024x202.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-1024x202.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-300x59.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229-768x152.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2026/02/11132241/image-229.png 1250w\" width=\"1024\"/></figure>\n<p>Photo via Shutterstock</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2413666699.HKD","symbol_name":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/02/50554299/xylem-analysts-lower-their-forecasts-after-q4-results","article_id":"2610950767","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2610950767","pubTimestamp":1770834235,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":" ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2413666699.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC","XYL":"赛莱默","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU2125910179.SGD":"Natixis Thematics Water H-R/A SGD","LU1721427968.SGD":"BNP PARIBAS AQUA \"CRH\" (SGDHDG) INC","LU2413666004.HKD":"BNP PARIBAS AQUA \"CRH\" (HKDHDG) INC","LU2272731865.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AM\" (HKD) INC","BK4161":"工业机械","LU1543694498.USD":"法巴水资源基金RH MD Dis","LU1992135472.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES \"AT\" (HKD) ACC","LU1620156213.USD":"BNP PARIBAS AQUA \"C\" (USD) INC","LU2413666426.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (HKD) ACC","LU2125910336.SGD":"Natixis Thematics Water R/A SGD","LU2322448957.HKD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AMG\" (HKD) INC","LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","LU1892829315.USD":"FIDELITY FUNDS SUSTAINABLE WATER & WASTE \"A\" (USD) ACC","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU2089279066.USD":"ALLIANZ GLOBAL WATER \"AT\" (USD) ACC","BK4585":"ETF&股票定投概念","LU1620156130.USD":"BNP PARIBAS AQUA \"C\" (USD) ACC","LU2413665964.HKD":"BNP PARIBAS AQUA \"C\" (HKD) ACC","LU1923621640.USD":"Natixis Thematics Water R/A USD","LU2322448791.USD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AMG\" (USD) INC","LU2473716301.USD":"ALLIANZ GLOBAL INTELLIGENT CITIES INCOME \"AMF\" (USD) INC","LU2394011477.USD":"JPMORGAN CLIMATE CHANGE SOLUTIONS \"A\" (USD) ACC","LU2360108059.USD":"BGF CIRCULAR ECONOMY \"A4\" (USD) INC","LU2298321311.HKD":"BGF CIRCULAR ECONOMY \"A\" (HKDHDG) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU2308191902.HKD":"BNP PARIBAS ECOSYSTEM RESTORATION \"CLASSIC\" (HKD) ACC","LU2023250843.SGD":"Allianz Thematica Cl AT Acc H2-SGD","LU2272731782.SGD":"Allianz Global Intelligent Cities AM Dis H2-SGD","LU1917777945.USD":"安联专题基金Cl AT Acc","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","LU2229751404.USD":"ALLIANZ GLOBAL WATER \"AT3\" (USD) ACC","LU2272731600.USD":"Allianz Global Intelligent Cities AM Dis USD","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","LU2092937221.SGD":"Blackrock Circular Economy A2 SGD-H","LU2041044095.USD":"Blackrock Circular Economy A2 USD","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","LU2240825500.USD":"AZ EQUITY - WATER & RENEWABLE RESOURCES \"A-AZ\" (USD) ACC","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","LU2211814178.USD":"ALLIANZ CLEAN PLANET \"AT\" (USD) ACC","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1165135440.EUR":"BNP Paribas Aqua Classic Cap EUR","BK4588":"碎股","LU1992135399.USD":"Allianz Global Intelligent Cities AT Acc USD","LU1596574779.USD":"BNP PARIBAS AQUA \"C\" (USDHDG) ACC"},"translate_title":"赛莱默分析师在第四季度业绩公布后下调预测","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XYL":1.5},"content_text":"Xylem Inc (NYSE:XYL) reported upbeat earnings for the fourth quarter on Tuesday.\nThe company posted quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.41 per share. The company reported quarterly sales of $2.397 billion which beat the analyst consensus estimate of $2.374 billion.\nXylem said it sees FY2026 adjusted EPS of $5.35-$5.56, versus market estimates of $5.56. The company sees sales of $9.100 billion-$9.200 billion, versus expectations of $9.331 billion.\n“The team delivered an exceptionally strong fourth quarter, capping a year of solid execution and transformation across Xylem,” said Matthew Pine, Xylem’s CEO. “We achieved record full-year revenue, adjusted EBITDA margin, and adjusted EPS, supported by broad-based demand across our largest end markets. Healthy organic revenue and orders growth gave us solid momentum coming into 2026.”\nXylem shares dipped 2.1% to trade at $126.24 on Wednesday.\nThese analysts made changes to their price targets on Xylem following earnings announcement.\n\nBarclays analyst William Grippin maintained Xylem with an Overweight rating and lowered the price target from $166 to $156.\nRBC Capital analyst Deane Dray maintained the stock with an Outperform rating and lowered the price target from $176 to $162.\n\nConsidering buying XYL stock? Here’s what analysts think: \n\nPhoto via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}